White, Douglas FRACP*†; Solanki, Kamal FRACP*†; Quincey, Vicki FRACP*†; Minett, Andrew MBChB‡; Tam, Gordon MBChB§; Doube, Alan FRACP*; Naden, Ray FRACP∥
From the *Rheumatology Department, Waikato Hospital, Hamilton; †Waikato Clinical School, University of Auckland; ‡Matamata Medical Centre, Matamata; §Midlands Health Network PHO, Hamilton, New Zealand; and ∥McMaster University, Hamilton, Ontario, Canada.
AbbVie, Ltd, supported this work through an unrestricted educational grant, which supported hire of the venue.
The authors declare no conflict of interest.
Correspondence: Douglas White, FRACP, Rheumatology Department, Waikato Hospital, Private Bag 3200, Hamilton, New Zealand. E-mail: [email protected].
Author Contributions: All authors were involved in drafting the article or revising it critically for important intellectual content, and all authors approved the final version to be published. D.W. and R.N. had full access to all of the data in the study and take responsibility for the integrity of the data and the accuracy of the data analysis. Study conception and design and acquisition, analysis, and interpretation of data: D.W. and R.N.
doi: 10.1097/RHU.0000000000000274
